-
Guanabenz Acetate: A Causal Assay Framework
2026-08-12
Guanabenz Acetate can serve as a precisely characterized α2-adrenergic receptor agonist for separating receptor-proximal signaling from stress-granule and innate-immune phenotypes. This article develops a compartment-aware assay strategy grounded in SARS-CoV-2 GADD34 research rather than simply treating viability or interferon output as standalone endpoints.
-
Doxycycline as a Controlled Variable in Cell Mechanics
2026-08-11
Doxycycline is more than a tetracycline antibiotic in research: its antimicrobial and metalloproteinase-inhibitory properties can become important experimental variables in 3D mechanobiology. This article connects the BA1003 compound profile with cell-tumbling research while defining controls that separate chemical effects from nuclear mechanotransduction.
-
Bifendate (DDB): From Hepatoprotection to Translation
2026-08-10
Bifendate (DDB) is more than a conventional hepatoprotective compound: its liver-directed lipid effects and context-dependent autophagy inhibition create a useful translational model for separating hepatic benefit from systemic lipid lowering. This article interprets the anchor mouse study, outlines practical experimental parameters, and defines the evidence gaps that matter before moving toward clinical relevance.
-
Vitamin C Workflows for Senescence and Cancer
2026-08-09
Build reproducible ascorbic acid assays for oxidative-stress senescence, cochlear-cell protection, and cancer research. This bench-focused guide connects dose design, orthogonal readouts, and stability control with practical troubleshooting for Vitamin C as a redox-active research reagent.
-
Capsaicin Protects BMSCs Through Autophagy
2026-08-08
This study identifies a TRPV1–Ca2+–autophagy response that helps rat bone marrow stromal cells retain viability and osteogenic capacity during hydrogen peroxide-induced oxidative stress. Its results connect capsaicin-mediated calcium signaling with reduced PI3K/AKT/mTOR phosphorylation, providing a mechanistic framework for studying BMSC dysfunction in osteoporosis.
-
Isorhamnetin: From PI3K/Akt Mechanism to Translation
2026-08-07
Isorhamnetin offers translational researchers more than a generic antioxidant model. Evidence from porcine oocyte maturation links its activity to PI3K/Akt activation, reduced oxidative and endoplasmic reticulum stress, and suppression of apoptosis, creating a practical framework for mechanism-led assay design and cautious translational positioning.
-
Cefepime (BMY-28142): Unraveling Antibiotic Kinetics & CNS U
2026-08-07
Explore the unique pharmacokinetics and assay implications of Cefepime (BMY-28142), a broad-spectrum cephalosporin antibiotic for advanced central nervous system infection research. This article delivers in-depth, evidence-backed insights on blood-brain barrier penetration and protocol optimization.
-
Cabozantinib (XL184): Systems Pharmacology and Adaptive Sign
2026-08-06
Discover how Cabozantinib (XL184) shapes adaptive phosphoproteomic networks and tumor cell behavior in renal cell carcinoma research. This article provides a systems-level analysis and practical guidance, offering a unique perspective beyond protocol optimization.
-
SFRP1 Attenuates Oral Submucous Fibrosis via Wnt/β-Catenin I
2026-08-06
This study demonstrates that SFRP1 overexpression reduces neutrophil infiltration and fibrosis in oral submucous fibrosis (OSF) by inhibiting the Wnt/β-catenin pathway in an arecoline-induced mouse model. The findings clarify the dual anti-fibrotic and immunomodulatory roles of SFRP1, highlighting Wnt pathway modulation as a promising target for fibrotic disease research.
-
Nigericin: Unlocking pH Modulation for Anticancer and Metabo
2026-08-05
Explore how Nigericin, a potassium/hydrogen ion carrier, enables precise intracellular pH modulation and reveals new anticancer and metabolic assay strategies. Discover unique technical guidance and comparative insights not found in existing literature.
-
Adenosine Triphosphate in Cellular Metabolism Research
2026-08-05
Unlock the full potential of Adenosine triphosphate (ATP) in dissecting mitochondrial enzyme regulation and purinergic signaling. This guide delivers actionable workflows, data-driven troubleshooting, and nuanced insights that set your cellular metabolism research apart.
-
Monomeric Amyloid Beta-Peptide (1-40) Suppresses Microglial
2026-08-04
A recent study uncovers a novel anti-inflammatory role for monomeric amyloid beta-peptide (1-40) in the brain, acting through an APP/heterotrimeric G protein pathway to inhibit microglial activation. These findings challenge traditional conceptions of amyloid beta solely as a pathogenic factor and offer new insights into immune regulation in Alzheimer’s disease.
-
Iptacopan (LNP023): Advanced Protocols for Complement Resear
2026-08-04
Iptacopan (LNP023) empowers precise inhibition of the alternative complement pathway, unlocking new specificity in both cellular and animal models of complement-mediated disease. This guide details protocol optimizations, practical troubleshooting, and emerging workflows, equipping researchers to maximize data reliability and translational impact.
-
COG133 Peptide Modulates Inflammation in Diabetic Wound Heal
2026-08-03
The reference study demonstrates that the ApoE-mimetic peptide COG133 enhances fibroblast migration, modulates miR-146a, and reduces pro-inflammatory signaling in diabetic wound models. These findings reveal a promising molecular strategy to address impaired wound healing and infection risk in diabetes.
-
ELF4 Drives Colorectal Cancer Metastasis via FGFR4 and SRC A
2026-08-03
This study uncovers how FGF19-driven upregulation of ELF4 promotes colorectal cancer (CRC) metastasis by activating FGFR4 and SRC. The findings highlight a clinically relevant, targetable signaling axis and demonstrate that dual inhibition of FGFR4 and SRC—using agents such as KX2-391 dihydrochloride—can suppress metastatic progression.
447 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page